NEW YORK (Reuters Health) – A high loading dose of clopidogrel — 600 mg — appears to be unnecessary in Asian patients with ST-segment elevation myocardial infarction (STEMI)…
NEW YORK (Reuters Health) – Stroke events are significantly less likely after carotid endarterectomy than after carotid artery stenting, particularly in the long term and among older patients,…
NEW YORK (Reuters Health) – The transvenous high-voltage leads of Medtronic’s Sprint Fidelis implantable cardioverter-defibrillator continue to deteriorate more rapidly than the earlier Medtronic Quattro Secure ICD leads,…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD), an impaired platelet response clopidogrel independently contributes to worse outcomes after percutaneous coronary intervention (PCI), a…
NEW YORK (Reuters Health) – After a first myocardial infarction, treatment with a calcium-channel blocker (CCB) does not appear to diminish the efficacy of clopidogrel, according to results…
NEW YORK (Reuters Health) – The use of artificial colloids for intravascular volume expansion is associated with greater risk of acute kidney injury and impaired coagulation than is…
NEW YORK (Reuters Health) – Patients with ST-elevation myocardial infarction (STEMI) who present 12 to 24 hours after onset of symptoms should be considered for reperfusion by primary…
NEW YORK (Reuters Health) – During the first year after coronary artery bypass grafting (CABG), patency rates are similar for radial artery grafts and saphenous vein grafts, study…
NEW YORK (Reuters Health) – For conversion of recent-onset atrial fibrillation, vernakalant acted more rapidly and was more effective than amiodarone in an international study. As reported in…
NEW YORK (Reuters Health) – In a prospective comparative study, 32-channel 3.0 Tesla magnetic resonance imaging (MRI) and 64-slice computed tomography (CT) angiography similarly identified significant coronary stenosis…